Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

27 July 2021
This July we have marked the 10-year anniversary of pharmacy technician registration It became a legal requirement for pharmacy technicians to register with the GPhC from 1 July 2011 and pharmacy...
27 July 2021
This month we published our new five-year strategy for how we will manage concerns about pharmacy professionals Our governing council agreed the finalised strategy in their meeting in June, following...
25 May 2021
Share your views on how we set our fees by 2 June 2021 We are asking for your views on how we set fees for registered pharmacists and pharmacy technicians, including our proposal to keep a flat fee...
25 May 2021
The GPhC is one of 12 partner organisations supporting a new national plan for inclusive pharmacy practice in England Chief Pharmaceutical Officer Dr Keith Ridge, Royal Pharmaceutical Society...
25 May 2021
Help us shape our approach to equality, diversity and inclusion  We are now consulting on our five-year strategy to deliver equality, improve diversity and foster inclusion. This strategy brings a...